Next-generation insulin developer Thermalin Diabetes is targeting an $8 million series B round of investment that would fund the first in-human studies of its insulin analogs.A successful clinical trial — though a long way off for the Cleveland-based company — would represent a huge milestone for Thermalin. CEO Rick Berenson said a positive trial would [...]

Next-generation insulin developer Thermalin Diabetes has closed a $2.85 million Series A investment round.The Cleveland-based startup plans to use the funding to step up production of its insulin analogs — new proteins engineered to act like insulin in the body — and continue preclinical testing.The insulin analogs are heat resistant, unlike the natural hormone, and [...]

Rick Berenson is charged with developing the business of one of Northeast Ohio’s most promising startups — Thermalin Diabetes, which is developing new forms of insulin called “insulin analogs.” The company is offering diabetes without the insulin side effects: it will last longer and have less cancer risk.

Thermalin Diabetes Inc. has been granted by Case Western Reserve University an exclusive license for a portfolio of insulin analogs, proteins engineered to act like insulin in the body.

Startup Thermalin Diabetes Inc. has raised $1.9 million in equity to commercialize new forms of insulin developed at Case Western Reserve University, according to a regulatory filing.

Thermalin Diabetes Inc., the Cleveland start-up that is developing new forms of insulin, has received a $250,000 investment commitment from JumpStart Ventures on the way to a Series A fundraising likely to be completed by the end of May.“It’s the first piece of what I think will be close to $2 million-worth of financing we’re [...]

Case Western Reserve University and University Hospitals Case Medical Center will participate in a consortium of national experts investigating why unexplained anemia is common in older adults. The consortium, called the Partnership for Anemia: Clinical and Translational Trials in the Elderly, is the result of a $16 million grant awarded by the National Institute on Aging.